Skip to main content
. 2020 Jul 10;19:103. doi: 10.1186/s12904-020-00610-4

Fig. 5.

Fig. 5

Overall survival (A,B,C) and progression-free survival (D,E,F) depending on baseline EORTC QLQ-C30 global score (A,D), baseline Karnofsky Index (B,E), and weight loss in the previous 3 months (C,F). Survival is presented as median (95% CI); p-values correspond to the Log-rank test for inter-curve differences